Most Popular
Sponsored
EVLV up 35.9% YTD, but posts $33M loss. Lane Generational buys $4.8M stake. Growth vs. profitability debate.
NVO down 7.5% YTD; competition heats up for Wegovy/Ozempic. Sell NVO at $46.
Strategy repays $1.5B debt, eyes Bitcoin sales for dividends. Stock up 18% YTD, below highs.
HIMS revenue misses but guides higher; EPS plunges. Strategic pivot impacts margins, AI investment ramps.
POET drops 9.4% after wider loss, but raises $400M at $21/share, diluting existing holders.
Nvidia, AMD, Intel slide 4-6% on China summit chip deal hopes dashed. AI fervor cools.
Ackman buys MSFT at 21x forward earnings, betting on AI-boosted Azure & 365 despite Q1 dip.
Sponsored
Must Read